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Evaluation of ExpressTM 5-PHM and Titanium® 5-PHM Bac®-1 on high-risk
receiving steers
Abstract
One backgrounding field study was conducted at two locations to compare the health and performance
of high-risk receiving steers given an ExpressTM 5-Pasteurella Haemolytica- Multocida (PHM) vaccine or
a Titanium® 5-PHM Bac®-1 vaccine. At one location, calves given the Titanium 5-PHM vaccination had
fewer first and second repulls (P<0.05). At the other location, calves given the Express 5-PHM vaccination
had fewer initial pulls for respiratory disease and more hospital pen days at initial pull (P<0.05) than those
given Titanium 5-PHM. No differences were measured at either location for mortality and average daily
gain.
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Cattlemen’s Day 2004

EVALUATION OF EXPRESSTM 5-PHM AND TITANIUM® 5-PHM BAC®-1 ON
HIGH-RISK RECEIVING STEERS1
M. P. Epp, D. A. Blasi, L. C. Hollis, and B. B. Barnhardt

ditions in U.S. feedyards (NAHMS, 1999) and
accounts for millions of dollars of loss to producers every year.

Summary
One backgrounding field study was conducted at two locations to compare the health
and performance of high-risk receiving steers
given an ExpressTM 5-Pasteurella Haemolytica-Multocida (PHM) vaccine or a Titanium® 5-PHM Bac®-1 vaccine. At one location, calves given the Titanium 5-PHM vaccination had fewer first and second repulls
(P<0.05). At the other location, calves given
the Express 5-PHM vaccination had fewer initial pulls for respiratory disease and more hospital pen days at initial pull (P<0.05) than
those given Titanium 5-PHM. No differences
were measured at either location for mortality
and average daily gain.

There are several types of BRD, pneumonia being the most prevalent form. Three factors must be present for pneumonia to develop: (1) stress, (2) viral infection, and (3)
bacterial infection. To help prevent the onset
of a viral infection, a modified live vaccine
with common respiratory antigen components
is used. Common respiratory viruses in cattle
include infectious bovine rhinotracheitis
(IBR), parainfluenza 3 (PI3), bovine virus diarrhea (BVD) type I and II, and bovine respiratory syncytial virus (BRSV). Two of the
most predominate types of bacterial infections
involved in pneumonia are Mannheimia (Pasteurella) haemolytica (PHM) and Pasteurella
multocida.

Introduction
Throughout the marketing chain, beef cattle can be introduced to many types of stressors and degrees of trauma, such as weaning,
exposure to pathogens and handling at salebarns, and long-distance hauling. Cattle that
are “high-risk” have experienced many excessive-trauma stressors over an extended period
and are classified as likely to acquire Bovine
Respiratory Disease complex (BRD). This
disease is ranked first among all disease con-

The objective of this study was to evaluate
two different modified live virus-pasteurella
combination vaccines, Express 5-PHM and
Titanium 5-PHM, on subsequent health and
performance of seriously stressed steers. Both
vaccines contain the same five modified live
viral components: IBR, PI3, BVD type I and
II, and BRSV. The vaccines differ in the form
of the Pasteurella haemolytica-multocida
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carried moderate flesh, but they were still considered to be high-risk calves. A final weight
was taken of all steers after an average of 84
days.

component: Express 5-PHM is in a killed
form, whereas in Titanium 5-PHM it is in a
modified live form.
Experimental Procedures

Results and Discussion
Location 1. A total of 736 steers (average
352 lb initial body weight) from the southeastern United States, were used at location 1 in
East-Central Kansas. These cattle were poorer
quality, light-weight, and high-risk calves.
Animals were randomly assigned to vaccine
treatments and given a metaphylactic treatment of Micotil®, an endectocide pour-on,
Revalor®-G growth implant, and were castrated/dehorned upon arrival. The cattle were
not assigned vaccine treatments on the basis of
castration status at time of arrival. Approximately 10 days later, a booster of the original
vaccine product without the Pasteurella
haemolytica- multocida component was given
to all steers except those in the hospital pen.
Sick animals were pulled and treated according to the standard protocol in use at this location. All cattle were fed a high-energy diet
based on corn silage. Uniform health and
management procedures were used throughout
the study. A final weight was taken of all
steers after an average of 93 days.

Health and performance data for the locations were not pooled because of the wide
range of differences in cattle quality and associated risk level. At location 1, there were
fewer first repulls (P<0.05) of non-castrate
calves (steers upon arrival) that had been
given the Titanium 5-PHM treatment (Table
1). There were fewer second repulls (P<0.05)
of castrates (bulls upon arrival). There were
no other significant differences among treatments at location 1 for initial pulls for respiratory disease, hospital pen days, percentage
death loss, and average daily gain.
At location 2, there were fewer initial pulls
for respiratory disease and more average hospital days when initially pulled (P<0.05) in
non-castrate calves (steers upon arrival) that
had been given the Express 5-PHM treatment
(Table 2). There were no other significant differences for the remaining measurements
taken at location 2.
Because performance between noncastrates (steers) and castrates (bulls) upon
arrival was not the primary focus of this study,
statistical analyses were not conducted for
these differences. Differences can be seen,
however, in initial pulls, death loss, and average daily gain. These differences were particularly marked for the cattle type used at location 1.

Location 2. All treatments and procedures at location 2 were the same as those
used at location 1, except that a 7-way clostridial vaccine and a Synovex®-S growth implant were given at initial processing. A total
of 422 steers (average 532 lb initial body
weight) originating from the southeastern
United States were used at location 2, which
was also in East-Central Kansas. These cattle
were better quality than those at location 1 and
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Table 1. Performance Differences Between Express 5-PHM Vaccine and Titanium 5-PHM Vaccine on % Pulls for Respiratory Disease, Treatment Days in Hospital Pen for Each Pull Occasion,
% Death Loss, and Average Daily Gain at Location 1
Item
Head
Initial Pulls, %*
First Repulls, %*
Second Repulls, %*

Non-Castrate (Steers)a
ExpressTM
Titanium®
89
74

Castrate (Bulls)
ExpressTM
Titanium®
282
291

38.8
22.3b
5.6

23.3
9.1c
1.1

51.2
23.4
9.2b

54.5
26.4
4.2c

Average Hospital Days
Initial Pulls*
First Repulls*
Second Repulls*

5.1
5.4
4.3

4.5
5.1
1.3

5.1
4.5
3.9

5.4
4.7
4.2

Death Loss, %*

7.1

10.0

16.3

18.0

Daily gain, lb*

2.0

2.2

1.7

1.8

a

Data analyzed separately according to castration status upon arrival.
Different superscripts between vaccines differ (P<0.05).
*Means blocked by load.
bc

Table 2. Performance Differences Between Express 5-PHM Vaccine and Titanium 5-PHM Vaccine on % Pulls for Respiratory Disease, Treatment Days in Hospital Pen for Each Pull Occasion,
% Death Loss, and Average Daily Gain at Location 2
Item
Head

Non-Castrate (Steers)a
ExpressTM
Titanium®
52
58

Castrate (Bulls)
ExpressTM
Titanium®
162
150

23.1b
3.5
0.5

43.1c
13.0c
8.3

42.0
16.0
5.6

48.0
16.0
4.0

Average Hospital Days
Initial Pulls*
First Repulls*
Second Repulls*

5.8b
3.3
0.0

3.5c
4.8
4.9

4.5
4.2
3.3

4.7
4.8
6.2

Death Loss, %*

6.1

2.5

6.1

5.2

Daily gain, lb*

2.7

2.7

2.3

2.2

Initial Pulls, %*
First Repulls, %*
Second Repulls, %*

a

Data analyzed separately according to castration status upon arrival.
Different superscripts between vaccines differ (P<0.05).
*Means blocked by load.
bc
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